Skip to search.
 FTSE 100 Down 0.95%

Regeneron Pharmaceuticals, Inc. (REGN)

-NasdaqGS
507.82 Up 2.85(0.56%) 15:28 - Nasdaq Real Time Price
Add to Portfolio
Prev Close:504.97
Open:512.20
Bid:508.03 x 200
Ask:509.13 x 100
1y Target Est:511.71
Beta:0.71
Earnings Date:3 Aug - 7 Aug (Est.)
Day's Range:505.67 - 514.80
52wk Range:285.06 - 544.00
Volume:122,729
Avg Vol (3m):776,253
Market Cap:53.45b
P/E (ttm):162.92
EPS (ttm):3.12
Div & Yield:N/A (N/A)
Trade Now
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
REGNUp 0.56%53.45b
AMGNUp 0.28%115.59b
NVSUp 0.37%239.35b
RHHBYUp 0.23%N/A

Key Statistics

Forward P/E (1 yr):37.80
P/S (ttm):16.85
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-15) :11.17
Quarterly EPS Est (Jun-15) :2.78
Mean Recommendation*:2.0
PEG Ratio (5 yr expected):2.33

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Regeneron Pharmaceuticals, Inc., a biopharmaceutical company, discovers, invents, develops, manufactures, and commercializes medicines for the treatment of serious medical conditions worldwide. more
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback